Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PDL1 Detection Set (Risk Free)

ELISA, FACS, ICC, IHC (p), WB, IF Reactivity: Human ELISA, FACS, ICC, IHC (p), WB, IF unconjugated Extracellular Domain Host: Mouse Monoclonal
Catalog No. ABIN6251785
  • Target See all PD-L1 products
    PD-L1 (CD274 (PD-L1))
    Binding Specificity
    Extracellular Domain
    Reactivity
    Human
    Host
    • 2
    • 1
    • 1
    Mouse
    Clonality
    Monoclonal
    Application
    ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB), Immunofluorescence (IF)
    Brand
    Risk-Free™
    Characteristics
    Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts.
    Purification
    Antibodies are supplied as protein A purified IgG1.
    Components
    PD-L1 Antibody [4F2]
    PD-L1 Antibody [8E12]
    PD-L1 Antibody [6H10]
    PD-L1 Antibody [2D6]
    PD-L1 Antibody [1F11]
    PD-L1 Antibody [1D7]
    Immunogen
    PD-L1 antibodies were raised against the extracellular domain of human PD-L1.
    Isotype
    IgG1
  • Comment

    Risk-Free™ antibodies are monoclonal antibodies made to improve in vitro studies.
    Unlike antibodies developed using proteins made in yeast or bacteria, Risk-Free™ antibodies are developed with antigens expressed in mammalian cell lines, giving the most native post-translational modifications to the protein.
    These antibodies have the following advantages:
    - Antibodies are developed against mammalian-expressed, post-translationally modified recombinant proteins.
    - Multiple antibodies per target allows the user to choose the best antibody for their application
    - Available individually or as a set
    - Risk-Free™ means they are rigorously tested and guaranteed to work for their designated applications:
    - ELISA
    - Flow Cytometry
    - Immunoblot
    - Immunohistochemistry
    - Immunocytochemistry
    - Immunofluorescence

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    PBS containing 0.02 % sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target
    PD-L1 (CD274 (PD-L1))
    Alternative Name
    PDL1 (PD-L1 Products)
    Synonyms
    B7-H Matched Antibody Pair, B7H1 Matched Antibody Pair, PD-L1 Matched Antibody Pair, PDCD1L1 Matched Antibody Pair, PDCD1LG1 Matched Antibody Pair, PDL1 Matched Antibody Pair, A530045L16Rik Matched Antibody Pair, B7h1 Matched Antibody Pair, Pdcd1l1 Matched Antibody Pair, Pdcd1lg1 Matched Antibody Pair, Pdl1 Matched Antibody Pair, RGD1566211 Matched Antibody Pair, CD274 molecule Matched Antibody Pair, CD274 antigen Matched Antibody Pair, programmed cell death 1 ligand 2 Matched Antibody Pair, CD274 Matched Antibody Pair, Cd274 Matched Antibody Pair, PDCD1LG2 Matched Antibody Pair
You are here:
Support